Find the latest Vascular Medicine news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.
Log in or Sign up for Free to view tailored content for your specialty!
May 26, 2026
6 min read
Save
Lp(a) and cardiovascular risk: What you should know
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
Visceral Fat Over Weight Loss; BP Control Incentive Backfires; PVCs Not Benign
A single lipoprotein(a) screening in a person’s lifetime could significantly reduce their risk for heart disease-related…
PHILADELPHIA — With several lipoprotein(a) therapies nearing market availability, physicians at the Heart in Diabetes CME…
Late-phase trials of targeted therapies for elevated lipoprotein(a) are nearing completion, with the first readouts expected…
Researchers analyzing over 20,000 patients found that very high levels of the inherited cholesterol particle Lp(a) dramatically…
ORLANDO — Ralinepag, a prostacyclin receptor agonist, added to background therapy decreased the risk for a clinical worsening…
GLP-1s may prevent adverse outcomes in patients with peripheral artery disease and diabetes, according to data published in the…
